A PHASE 1, SINGLE DOSE PK AND SAFETY STUDY WITH NI-03 FOLLOWED BY A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NI-03 COMPARED TO PLACEBO IN SUBJECTS WITH CHRONIC PANCREATIs
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
KC Specialty Therapeutics
Start Date
February 1, 2016
End Date
January 31, 2020
Administered By
Medicine, Gastroenterology
Awarded By
KC Specialty Therapeutics
Start Date
February 1, 2016
End Date
January 31, 2020